Flagship explainer
How BioMarin Pharmaceutical Inc makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $3.2B | 100% |
| |
| Cost of revenue | $717M | 22% |
|
| $2.5B | 78% |
| |
| $409M | 13% |
| |
| Income before tax | $482M | 15% |
|
| Income tax | $134M | 4% |
|
| $349M | 11% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001048477-26-000004